Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
261 | 18876 | 36.2 | 76% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
48 | 92304 | HAEMOPHILIA//HEMATOLOGY//THROMBOSIS AND HAEMOSTASIS |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PROTEIN C | Author keyword | 523 | 58% | 3% | 610 |
2 | ACTIVATED PROTEIN C | Author keyword | 436 | 71% | 2% | 348 |
3 | TISSUE FACTOR | Author keyword | 420 | 39% | 4% | 837 |
4 | THROMBOMODULIN | Author keyword | 382 | 55% | 3% | 480 |
5 | PROTEIN S | Author keyword | 311 | 58% | 2% | 354 |
6 | TISSUE FACTOR PATHWAY INHIBITOR | Author keyword | 295 | 65% | 1% | 277 |
7 | THROMBOSIS AND HAEMOSTASIS | Journal | 261 | 16% | 8% | 1514 |
8 | FACTOR V LEIDEN | Author keyword | 254 | 47% | 2% | 404 |
9 | ANTITHROMBIN | Author keyword | 246 | 48% | 2% | 378 |
10 | THROMBOSIS RESEARCH | Journal | 231 | 15% | 8% | 1434 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROTEIN C | 523 | 58% | 3% | 610 | Search PROTEIN+C | Search PROTEIN+C |
2 | ACTIVATED PROTEIN C | 436 | 71% | 2% | 348 | Search ACTIVATED+PROTEIN+C | Search ACTIVATED+PROTEIN+C |
3 | TISSUE FACTOR | 420 | 39% | 4% | 837 | Search TISSUE+FACTOR | Search TISSUE+FACTOR |
4 | THROMBOMODULIN | 382 | 55% | 3% | 480 | Search THROMBOMODULIN | Search THROMBOMODULIN |
5 | PROTEIN S | 311 | 58% | 2% | 354 | Search PROTEIN+S | Search PROTEIN+S |
6 | TISSUE FACTOR PATHWAY INHIBITOR | 295 | 65% | 1% | 277 | Search TISSUE+FACTOR+PATHWAY+INHIBITOR | Search TISSUE+FACTOR+PATHWAY+INHIBITOR |
7 | FACTOR V LEIDEN | 254 | 47% | 2% | 404 | Search FACTOR+V+LEIDEN | Search FACTOR+V+LEIDEN |
8 | ANTITHROMBIN | 246 | 48% | 2% | 378 | Search ANTITHROMBIN | Search ANTITHROMBIN |
9 | TAFI | 226 | 80% | 1% | 139 | Search TAFI | Search TAFI |
10 | FACTOR V | 210 | 61% | 1% | 220 | Search FACTOR+V | Search FACTOR+V |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ACTIVATED PROTEIN C | 772 | 39% | 8% | 1542 |
2 | BLOOD COAGULATION | 722 | 37% | 8% | 1581 |
3 | COAGULATION FACTOR V | 632 | 64% | 3% | 613 |
4 | FACTOR XA | 571 | 49% | 4% | 844 |
5 | POOR ANTICOAGULANT RESPONSE | 531 | 70% | 2% | 440 |
6 | COAGULATION INHIBITOR | 441 | 81% | 1% | 268 |
7 | HUMAN ALPHA THROMBIN | 419 | 63% | 2% | 418 |
8 | PROTEIN C | 405 | 39% | 4% | 831 |
9 | DISSEMINATED INTRAVASCULAR COAGULATION | 372 | 33% | 5% | 918 |
10 | PEPTIDE BOND CLEAVAGES | 359 | 98% | 0% | 93 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | THROMBOSIS AND HAEMOSTASIS | 261 | 16% | 8% | 1514 |
2 | THROMBOSIS RESEARCH | 231 | 15% | 8% | 1434 |
3 | BLOOD COAGULATION & FIBRINOLYSIS | 126 | 19% | 3% | 584 |
4 | JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 79 | 14% | 3% | 511 |
5 | SEMINARS IN THROMBOSIS AND HEMOSTASIS | 44 | 13% | 2% | 323 |
6 | HAEMOSTASIS | 44 | 18% | 1% | 222 |
7 | CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | 31 | 14% | 1% | 208 |
8 | PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS | 12 | 17% | 0% | 62 |
9 | RESEARCH IN CLINIC AND LABORATORY | 1 | 10% | 0% | 8 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The cytoprotective protein C pathway | 2007 | 348 | 108 | 85% |
Inflammation and coagulation | 2010 | 162 | 119 | 76% |
MECHANISMS OF DISEASE The Coagulopathy of Chronic Liver Disease | 2011 | 219 | 61 | 41% |
Biology of tissue factor pathway inhibitor | 2014 | 9 | 122 | 86% |
Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway | 2013 | 30 | 105 | 72% |
Advances in understanding pathogenic mechanisms of thrombophilic disorders | 2008 | 126 | 83 | 86% |
The interactions between inflammation and coagulation | 2005 | 312 | 120 | 65% |
Medical progress: Genetic susceptibility to venous thrombosis. | 2001 | 449 | 91 | 77% |
Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis | 2007 | 176 | 84 | 67% |
Tissue factor in cardiovascular diseases - Molecular mechanisms and clinical implications | 2006 | 229 | 99 | 61% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARDIOVASC BIOL PROGRAM | 36 | 28% | 0.6% | 107 |
2 | U428 | 29 | 47% | 0.2% | 47 |
3 | SYN SE BV | 29 | 72% | 0.1% | 23 |
4 | UNITAT HEMOSTASIA TROMBOSI | 24 | 57% | 0.2% | 29 |
5 | TISSUE TOR TOR 7 | 24 | 91% | 0.1% | 10 |
6 | PHYS BIOCHEM BLOOD | 23 | 100% | 0.1% | 10 |
7 | HEMOSTASIS THROMBOSIS | 19 | 21% | 0.4% | 81 |
8 | HAEMOSTASIS BIOCHEM | 19 | 64% | 0.1% | 18 |
9 | SECT GEN EXPT PATHOL | 17 | 79% | 0.1% | 11 |
10 | THROMBOSIS HAEMOSTASIS | 16 | 17% | 0.5% | 86 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000022419 | PURPURA FULMINANS//SYMMETRICAL PERIPHERAL GANGRENE//CARCINOCYTHEMIA |
2 | 0.0000019027 | DYSFIBRINOGENEMIA//AFIBRINOGENEMIA//DYSFIBRINOGEN |
3 | 0.0000016024 | HEPARIN INDUCED THROMBOCYTOPENIA//ARGATROBAN//LEPIRUDIN |
4 | 0.0000014069 | HAEMOPHILIA//HAEMOPHILIA A//VON WILLEBRAND DISEASE |
5 | 0.0000012393 | PULMONARY EMBOLISM//VENOUS THROMBOEMBOLISM//DEEP VEIN THROMBOSIS |
6 | 0.0000012108 | UROKINASE RECEPTOR//FIBRINOLYSIS//PAI 1 |
7 | 0.0000010492 | WARFARIN//CYP2C9//VKORC1 |
8 | 0.0000009379 | BRADYKININ//FACTOR XII//B 1 RECEPTOR |
9 | 0.0000008710 | BOWMAN BIRK INHIBITOR//PROTEASE ACTIVATED RECEPTOR//CYCLOTIDES |
10 | 0.0000008565 | RENAL VEIN THROMBOSIS//NEPHROL UROL TRANSPLANT IMMUNOL DERMATOL A//NEPHROTIC EDEMA |